Truvvo Partners’s Amgen AMGN Stock Holding History

Truvvo Partners’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-2,700	Closed	-$405K	–	122
2016 Q1	$405K	Buy	+2,700	New	+$401K	0.18%	96

Other funds holding AMGN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Truvvo Partners's AMGN Position: Q2 2016 in Review

Truvvo Partners sold out of Amgen (AMGN) in Q2 2016, closing a stake of 2,700 shares — an estimated $405K sold.

Truvvo Partners first reported a position in AMGN in Q1 2016 and held it in 1 quarter. The position peaked at $405K in Q1 2016. 1,472 funds tracked by Wall St. Rank hold AMGN as of Q2 2016.

Truvvo Partners reported no remaining Amgen position as of Q2 2016 after selling out during the quarter.
Truvvo Partners sold 2,700 Amgen shares in Q2 2016, an estimated $405K.
Truvvo Partners first reported a position in Amgen in Q1 2016 and held it in 1 quarter.
Truvvo Partners's Amgen position peaked at $405K in Q1 2016.
1,472 funds tracked by Wall St. Rank held Amgen as of Q2 2016.

Based on Truvvo Partners's 13F filing for Q2 2016, filed 9 Aug 2016.